CCCCCCCCCCCCC\C=C\[C@@H] (O) [C@H] (CO[C@@H] 1O[C@H] (CO) [C@@H] (O[C@@H] 2O[C@H] (CO) [C@H] (O[C@H] 3O[C@H] (CO) [C@H] (O) [C@H] (O[C@@H] 4O[C@H] (CO) [C@H] (O) [C@H] (O) [C@H] 4NC(C) =O) [C@H] 3O) [C@H] (O) [C@H] 2O) [C@H] (O) [C@H] 1O) NC([*] ) =O |
|
Mus musculus
(NCBI:txid10090)
|
Source: BioModels - MODEL1507180067
See:
PubMed
|
Homo sapiens
(NCBI:txid9606)
|
See:
DOI
|
human metabolite
Any mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
(via N-acetyl-beta-D-galactosaminyl-(1->3)-alpha-D-galactosyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosylceramide )
mouse metabolite
Any mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
(via N-acetyl-beta-D-galactosaminyl-(1->3)-alpha-D-galactosyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosylceramide )
antigen
Any substance that stimulates an immune response in the body, such as through antibody production or by presentation to a T-cell receptor after binding to a major histocompability complex (MHC).
(via N-acetyl-beta-D-galactosaminyl-(1->3)-alpha-D-galactosyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosylceramide )
|
|
View more via ChEBI Ontology
Outgoing
|
N- acetyl- β- D- galactosaminyl- (1→3)- α- D- galactosyl- (1→4)- β- D- galactosyl- (1→4)- β- D- glucosylceramide
(CHEBI:18259)
has part
→4)-α-D-Galp-(1→4)-β-D-Galp-(1→4)-β-D-Glcp-yl group
(CHEBI:142533)
N- acetyl- β- D- galactosaminyl- (1→3)- α- D- galactosyl- (1→4)- β- D- galactosyl- (1→4)- β- D- glucosylceramide
(CHEBI:18259)
has part
α-D-Galp-(1→4)-β-D-Galp-(1→4)-β-D-Glcp-yl group
(CHEBI:142567)
N- acetyl- β- D- galactosaminyl- (1→3)- α- D- galactosyl- (1→4)- β- D- galactosyl- (1→4)- β- D- glucosylceramide
(CHEBI:18259)
has role
antigen
(CHEBI:59132)
N- acetyl- β- D- galactosaminyl- (1→3)- α- D- galactosyl- (1→4)- β- D- galactosyl- (1→4)- β- D- glucosylceramide
(CHEBI:18259)
has role
human metabolite
(CHEBI:77746)
N- acetyl- β- D- galactosaminyl- (1→3)- α- D- galactosyl- (1→4)- β- D- galactosyl- (1→4)- β- D- glucosylceramide
(CHEBI:18259)
has role
mouse metabolite
(CHEBI:75771)
N- acetyl- β- D- galactosaminyl- (1→3)- α- D- galactosyl- (1→4)- β- D- galactosyl- (1→4)- β- D- glucosylceramide
(CHEBI:18259)
is a
N-acetyl-β-D-galactosaminyl-(1→3)-α-D-galactosyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1ʼ)-ceramide
(CHEBI:88167)
N- acetyl- β- D- galactosaminyl- (1→3)- α- D- galactosyl- (1→4)- β- D- galactosyl- (1→4)- β- D- glucosylceramide
(CHEBI:18259)
is a
globoside
(CHEBI:61360)
N- acetyl- β- D- galactosaminyl- (1→3)- α- D- galactosyl- (1→4)- β- D- galactosyl- (1→4)- β- D- glucosylceramide
(CHEBI:18259)
is a
glycotetraosylceramide
(CHEBI:23075)
|
|
Incoming
|
β-D-GalNAc-(1→3)-β-D-GalNAc-(1→3)-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1ʼ)-N-acylsphingosine
(CHEBI:140784)
has functional parent
N- acetyl- β- D- galactosaminyl- (1→3)- α- D- galactosyl- (1→4)- β- D- galactosyl- (1→4)- β- D- glucosylceramide
(CHEBI:18259)
SO3-3β-D-GalNAc-(1→3)-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1ʼ)-ceramide(d18:1 (4E))
(CHEBI:141158)
has functional parent
N- acetyl- β- D- galactosaminyl- (1→3)- α- D- galactosyl- (1→4)- β- D- galactosyl- (1→4)- β- D- glucosylceramide
(CHEBI:18259)
N-acetyl-β-D-galactosaminyl-(1→3)-α-D-galactosyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosylceramide (d18:1/16:0)
(CHEBI:132968)
is a
N- acetyl- β- D- galactosaminyl- (1→3)- α- D- galactosyl- (1→4)- β- D- galactosyl- (1→4)- β- D- glucosylceramide
(CHEBI:18259)
N-acetyl-D-galactosaminyl-(1→3)-D-galactosyl-(1→4)-D-galactosyl-(1→4)-D-glucosyl-N-stearoylceramide
(CHEBI:52988)
is a
N- acetyl- β- D- galactosaminyl- (1→3)- α- D- galactosyl- (1→4)- β- D- galactosyl- (1→4)- β- D- glucosylceramide
(CHEBI:18259)
globoside Gb4
(CHEBI:84125)
is a
N- acetyl- β- D- galactosaminyl- (1→3)- α- D- galactosyl- (1→4)- β- D- galactosyl- (1→4)- β- D- glucosylceramide
(CHEBI:18259)
|
N- [(2S,3R,4E)- 1- {[2- acetamido- 2- deoxy- β- D- galactopyranosyl- (1→3)- α- D- galactopyranosyl- (1→4)- β- D- galactopyranosyl- (1→4)- β- D- glucopyranosyl]oxy}- 3- hydroxyoctadec- 4- en- 2- yl]alkanamide
|
(Gal)2 (GalNAc)1 (Glc)1 (Cer)1
|
KEGG GLYCAN
|
a globoside Gb4Cer (d18:1(4E))
|
UniProt
|
β- D- GalNAc- (1→3)- α- D- Gal- (1→4)- β- D- Gal- (1→4)- β- D- Glc- (1↔1')- Cer
|
JCBN
|
β- D- GalpNAc- (1→3)- α- D- Galp- (1→4)- β- D- Galp- (1→4)- β- D- Glcp- (1↔1')- Cer
|
JCBN
|
CTH/Gb4
|
ChEBI
|
GalNAc-1→3-Gal-1→4-Gal-1→4-Glc-Cer
|
ChemIDplus
|
GalNAcβ1-3-Galα1-4Galβ1-4Glcβ1-1Cer
|
ChEBI
|
Gb4 Globoside
|
ChemIDplus
|
Gb4 Globotetraosyl ceramide
|
ChemIDplus
|
Gb4Cer
|
ChemIDplus
|
Gb4Cer
|
KEGG GLYCAN
|
Gbose4Cer
|
ChemIDplus
|
GbOse4Cer
|
ChEBI
|
Globoside GL-4
|
ChemIDplus
|
Globoside I
|
KEGG COMPOUND
|
Globotetraosyl ceramide
|
ChemIDplus
|
N- acetyl- D- galactosaminyl- (1→3)- D- galactosyl- (1→4)- D- galactosyl- (1→4)- D- glucosylceramides
|
ChEBI
|
N-Acetyl-D-galactosaminyl-1,3-D-galactosyl-1,4-D-galactosyl-1,4-D-glucosylceramide
|
KEGG COMPOUND
|
N-Acetyl-galactosaminyl-1,3-D-galactosyl-1,4-D-galactosyl-1,4-D-glucosylceramide
|
KEGG COMPOUND
|
Slt-iiv receptor
|
ChemIDplus
|
VT2vp1 Receptor
|
ChemIDplus
|
11034-93-8
|
CAS Registry Number
|
KEGG COMPOUND
|
11034-93-8
|
CAS Registry Number
|
ChemIDplus
|
1528196
|
PubMed citation
|
Europe PMC
|
15495792
|
PubMed citation
|
Europe PMC
|
15661151
|
PubMed citation
|
Europe PMC
|
1601891
|
PubMed citation
|
Europe PMC
|
1724444
|
PubMed citation
|
Europe PMC
|
21252262
|
PubMed citation
|
Europe PMC
|
21376640
|
PubMed citation
|
Europe PMC
|
2448252
|
PubMed citation
|
Europe PMC
|
2456994
|
PubMed citation
|
Europe PMC
|
3220436
|
PubMed citation
|
Europe PMC
|
4026313
|
PubMed citation
|
Europe PMC
|
7287743
|
PubMed citation
|
Europe PMC
|
7690848
|
PubMed citation
|
Europe PMC
|
7691279
|
PubMed citation
|
Europe PMC
|
8161226
|
PubMed citation
|
Europe PMC
|
|